Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.

Saghafi R, Brown C, Butters MA, Cyranowski J, Dew MA, Frank E, Gildengers A, Karp JF, Lenze EJ, Lotrich F, Martire L, Mazumdar S, Miller MD, Mulsant BH, Weber E, Whyte E, Morse J, Stack J, Houck PR, Bensasi S, Reynolds CF 3rd.

Int J Geriatr Psychiatry. 2007 Nov;22(11):1141-6.

2.

Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.

Lavretsky H, Alstein LL, Olmstead RE, Ercoli LM, Riparetti-Brown M, Cyr NS, Irwin MR.

Am J Geriatr Psychiatry. 2011 Oct;19(10):839-50. doi: 10.1097/JGP.0b013e31820ee9ef.

3.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
4.
5.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.

Curr Med Res Opin. 2006 Jul;22(7):1331-41.

PMID:
16834832
6.

Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram.

Papakostas GI, Larsen K.

Eur Arch Psychiatry Clin Neurosci. 2011 Apr;261(3):147-56. doi: 10.1007/s00406-010-0149-3.

PMID:
20859636
7.

Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study.

Brown ES, Howard C, Khan DA, Carmody TJ.

Psychosomatics. 2012 Jan-Feb;53(1):75-80. doi: 10.1016/j.psym.2011.07.009.

PMID:
22221724
8.

Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.

Dolberg O, Larsson Lönn S, Kvist K.

Curr Med Res Opin. 2014 Jul;30(7):1301-7. doi: 10.1185/03007995.2014.904770.

PMID:
24628498
9.

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S.

Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004.

PMID:
19709754
10.
11.

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report.

Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, Trivedi MH, Rush AJ; CO-MED Study Team..

Psychol Med. 2013 May;43(5):945-60. doi: 10.1017/S0033291712001742.

PMID:
23228340
12.
13.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
15.

Clinical and functional outcomes of patients who experience partial response to citalopram: secondary analysis of STAR*D.

Dennehy EB, Marangell LB, Martinez J, Balasubramani GK, Wisniewski SR.

J Psychiatr Pract. 2014 May;20(3):178-87. doi: 10.1097/01.pra.0000450317.76117.62.

PMID:
24847991
16.

Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.

Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):248-60. doi: 10.1016/j.drugalcdep.2008.08.010.

PMID:
18986774
17.

Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.

Demyttenaere K, Andersen HF, Reines EH.

Int Clin Psychopharmacol. 2008 Sep;23(5):276-86. doi: 10.1097/YIC.0b013e328303ac5f.

PMID:
18703937
19.

Apathy in late-life depression: common, persistent, and disabling.

Yuen GS, Bhutani S, Lucas BJ, Gunning FM, AbdelMalak B, Seirup JK, Klimstra SA, Alexopoulos GS.

Am J Geriatr Psychiatry. 2015 May;23(5):488-94. doi: 10.1016/j.jagp.2014.06.005.

20.

Escitalopram in the treatment of anxiety symptoms associated with depression.

Bandelow B, Andersen HF, Dolberg OT.

Depress Anxiety. 2007;24(1):53-61.

PMID:
16937393
Items per page

Supplemental Content

Support Center